z-logo
Premium
Human renal fibroblasts generate dendritic cells with a unique regulatory profile
Author(s) -
Dixon Karen O,
Rossmann Laura,
Kamerling Sylvia WA,
Kooten Cees
Publication year - 2014
Publication title -
immunology and cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.999
H-Index - 104
eISSN - 1440-1711
pISSN - 0818-9641
DOI - 10.1038/icb.2014.41
Subject(s) - microbiology and biotechnology , chemistry , biology
Fibroblasts reside within the renal interstitium in close proximity to neighbouring dendritic cells (DCs). It is likely that these cells have a central role in the maintenance and function of resident and infiltrating renal DCs, though studies to confirm this have been lacking. We investigated whether renal fibroblasts influence human DC generation and function. We found that co‐culture with renal fibroblasts led to the generation of monocyte‐derived dendritic cells (Fibro‐DCs), with significantly reduced CD80, CD83 and CD86 but elevated B7H1 and B7DC expression. In addition, these Fibro‐DCs displayed a reduced capacity to produce interleukin (IL)‐12p40 and IL‐12p70 but maintained normal levels of IL‐23 and IL‐27. Furthermore, IL‐10 production was elevated, which together resulted in a regulatory DC population with a reduced capacity to stimulate allogenic T‐cell proliferation and interferon γ production, while preserving IL‐17A. Supernatant transfer experiments suggested that a soluble mediator from the fibroblasts was sufficient to inhibit the immunogenic capability of DCs. Further experiments demonstrated that IL‐6 was at least partially responsible for the modulating effect of renal fibroblasts on DC generation and subsequent function. In summary, renal fibroblasts may have a crucial decisive role in regulating local DC immune responses in vivo . Better understanding of this cell population and their mechanisms of action may have therapeutic relevance in many immune‐driven renal diseases.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here